News for CARDIOME PHARMA CORP - Google Finance

Cardiome Reports First Quarter Results

Mon, 13 May 2013 13:06:46 GMT

Cardiome Reports First Quarter Results
Canada NewsWire (press release) - May 13, 2013

VANCOUVER, May 13, 2013 /CNW/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today reported financial results for the first quarter ended March 31, 2013.

Cardiome Pharma (CRME) Announces Quarterly Earnings Results, Misses ... - The Utah People's Post

Cardiome Accepts the Transfer of Sponsorship of US and Canadian Vernakalant ...

Thu, 02 May 2013 16:01:18 GMT

Cardiome Accepts the Transfer of Sponsorship of US and Canadian Vernakalant ...
Canada NewsWire (press release) - May 2, 2013

VANCOUVER, May 2, 2013 /CNW/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced completion of the transfer of sponsorship of the U.S.

Stocks In Negative Territory: American DG Energy Inc (NYSEMKT:ADGE ... - NIS

Cardiome Announces Worldwide Sales And Marketing Of BRINAVESS™

Thu, 25 Apr 2013 17:55:04 GMT

Cardiome Announces Worldwide Sales And Marketing Of BRINAVESS™
Canada NewsWire (press release) - Apr 25, 2013

VANCOUVER, April 25, 2013 /CNW/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it has taken on responsibility for worldwide sales, marketing, and promotion of BRINAVESS™ (vernakalant IV) pursuant to a Transition ...

Cardiome accepts transfer of sponsorship of US & Canadian vernakalant IV and ...

Sat, 04 May 2013 06:37:55 GMT

Cardiome accepts transfer of sponsorship of US & Canadian vernakalant IV and ...
pharmabiz.com - May 4, 2013

Cardiome Pharma Corp. has completed the transfer of sponsorship of the US Investigational New Drug Applications for vernakalant intravenous (IV) and oral, and the transfer of the US New Drug Application for vernakalant IV from Merck Sharp & Dohme ...

US/Canada daily earnings hits & misses May 13 - 1800 ET

Mon, 13 May 2013 12:01:20 GMT

US/Canada daily earnings hits & misses May 13 - 1800 ET
Reuters - May 13, 2013

... CORP Q1 UNDESIGNATED CONR SVC USD -0.01 0.00 0.01 4.5 4.4 -0.1 CAPSTONE INFRASTRUCTURE Q1 ELECTRICAL UTILITIES CAD 0.13 -- -- 95.4 94.3 -1.1 CARDIOME PHARMA CORP Q1 DRUGS USD -- -- -- -- 0.1 -- CARDIOME PHARMA CORP ...

Earnings Scheduled For May 13, 2013

Mon, 13 May 2013 08:45:08 GMT

Earnings Scheduled For May 13, 2013
Benzinga - May 13, 2013

Cardiome Pharma Corp. (NASDAQ: CRME) is projected to report its Q1 earnings on revenue of $1.60 million. Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) is estimated to report its Q1 earnings at $0.28 per share on revenue of $12.81 million.

Daniel P. Bednarik, Ph.D. Joins BioHealth Innovation Commercial Relevance ...

Mon, 06 May 2013 07:25:15 GMT

Daniel P. Bednarik, Ph.D. Joins BioHealth Innovation Commercial Relevance ...
Virtual-Strategy Magazine (press release) - May 6, 2013

Dr. Bednarik was formerly Director of Genomics and Bioinformatics for Cardiome Pharma Corporation. He was previously co-founder and Vice President of Cardiovascular Biology of Artesian Therapeutics, Inc., which was acquired by Cardiome in 2005.

Cardiome Pharma Corp Announces Changes To Senior Management Team

Tue, 26 Mar 2013 23:24:00 GMT

Cardiome Pharma Corp Announces Changes To Senior Management Team
Reuters Key Development - Mar 26, 2013

Merck & Co Inc Returns Global Marketing And Development Rights For Vernakalant To Cardiome Pharma Corp

Wed, 26 Sep 2012 12:04:00 GMT

Merck & Co Inc Returns Global Marketing And Development Rights For Vernakalant To Cardiome Pharma Corp
Reuters Key Development - Sep 26, 2012

Cardiome Pharma Corp Announces Appointment of Jennifer Archibald as Chief Financial Officer

Thu, 20 Sep 2012 20:30:00 GMT

Cardiome Pharma Corp Announces Appointment of Jennifer Archibald as Chief Financial Officer
Reuters Key Development - Sep 20, 2012